Measures of Global Risk: Old Versus New Methods

References

• Labarthe D R. Chapter 3, Atherosclerosis. Epidemiology and Prevention of Cardiovascular Diseases: A Global Challenge, D R Labarthe. Aspen Publishers Inc. 1998, ISBN 0‐8342‐0659‐5
   Google Scholar
• Prospective Studies Collaboration. Age‐specific relevance of usual blood pressure to vascular mortality: a meta‐analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913
   Google Scholar
• Stamler J. Established major coronary risk factors. Coronary Heart Disease Epidemiology: From Aetiology to Public Health, M Marmot, P Elliott. Oxford Medical Publications. 1992, ISBN 019 2621246
   Google Scholar
• Tunstall‐Pedoe H. The Dundee coronary risk‐disk for management of change in risk factors. Br Med J 1991; 303: 744–747, [CSA]
   Google Scholar
• Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J 1993; 306: 983–987
   Google Scholar
• Chatellier G, Blinowska A, Menard J, Degoulet P. Do physicians estimate reliably the cardiovascular risk of hypertensive patients?. Med Inform 1995; 8: 876–879
   Google Scholar
• Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446, [CROSSREF], [CSA]
   Google Scholar
• Ogden L G, He J, Lydick E, Whelton P K. Long‐term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI Risk Stratification. Hypertension 2000; 34: 539–543, [CSA]
   Google Scholar
• Guidelines Subcommittee. 1999 World Health Organization–International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151–183
   Google Scholar
• World Health Organization–International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)–International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983–1992, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Shaper A G, Pocock S J, Philips A N, Walker M. Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J 1986; 293: 474–479
   Google Scholar
• Assman G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 1‐year follow‐up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310–315, [CROSSREF]
   Google Scholar
• Anderson K M, Wilson P W, Odell P M, Kannel W B. An updated coronary risk profile: a statement for health professionals. Circulation 1991; 83: 356–362, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Shaper A G, Wannamethee G, Macfarlane P W, Walker M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle‐aged British men. Br Heart J 1993; 70: 49–55, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Miettinen H, Haffner S M, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non‐insulin‐dependent diabetic subjects. Stroke 1996; 27: 2033–2039, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• National Institutes of Health Consensus Development Program. Physical activity and cardiovascular health. NIH Consens Statement December 18–20, 1995; 13(3)1–33, [CSA]
   Google Scholar
• Ridker P M. High‐sensitivity C‐reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813–1818, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Chang C L, Donaghy M, Poulter N R. Migraine and stroke in young women: a case‐control study. Br Med J 1999; 318: 13–18
   Google Scholar
• Khaw K T, Wareham N, Luben R, Bingham S, Oakes S, Welch A. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC–NORFOLK). Br Med J 2001; 322: 15–18
   Google Scholar
• UKPDS group. The UKPDS risk engine: a model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56). Clin Sci 2001; 101: 671–679, [CROSSREF]
   Google Scholar
• Haq I U, Ramsay L E, Yeo W W, Jackson P R, Wallis E J. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999; 81: 40–46, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Pyorala K, De Backer G, Graham I, Poole‐Wilson P, Wood D, on behalf of the Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 110: 121–161
   Google Scholar
• Pyorala K, De Backer G, Graham I, Poole‐Wilson P, Wood D, on behalf of the Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Int Soc Hypertens News 1995; 1: 6–12
   Google Scholar
• Jackson R. Updated New Zealand cardiovascular disease risk‐benefit prediction guide. Br Med J 2000; 320: 709–710
   Google Scholar
• Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray (for the British Cardiac Society) R, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80: S1–S29
   Google Scholar
• Anonymous. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143–3421
   Google Scholar
• Baker S, Priest P, Jackson R. Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated. Br Med J 2000; 320: 680–685
   Google Scholar
• Pocock S J, McCormack V, Gueyffier F, Boutitie F, Fagard R H, Boissel J‐P, on behalf of the INDANA Project Steering Committee. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. Br Med J 2001; 323: 75–81
   Google Scholar
• Williams B, Poulter N, Brown M, Davies M, McInnes G, Potter J, Sever P, Thom S M. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society 2004‐BHS IV. J Hum Hypertens 2004; 18: 139–185, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Conroy R M, Pyorala K, Fitzgerald A P, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti J, Keil U, Njolstad I, Oganov R G, Thomsen T, Tunstall‐Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham I M, on behalf of the SCORE Project Group. Estimation of ten‐year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Haffner S M, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl J Med 1998; 339: 229–234, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Evans J MM, Wang J, Morris A D. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had a myocardial infarction: cross sectional and cohort studies. Br Med J 2002; 324: 939–943
   Google Scholar